Campo C - Search Results

1

Should we perform an echocardiogram in hypertensive patients classified as having low and medium risk?

Suárez C, Villar J, Martel N, Extremera BG, Suliman N, Campo C, Castellanos V, Liébana A, Rodilla E, Nieto J, Velasco O, Ruilope LM; GESTHA Study Group. Suárez C, et al. Among authors: campo c. Int J Cardiol. 2006 Jan 4;106(1):41-6. doi: 10.1016/j.ijcard.2004.12.076. Int J Cardiol. 2006. PMID: 16321664

2

Proteinuria: an underappreciated risk factor in cardiovascular disease.

Segura J, Campo C, Ruilope LM. Segura J, et al. Among authors: campo c. Curr Cardiol Rep. 2002 Nov;4(6):458-62. doi: 10.1007/s11886-002-0106-5. Curr Cardiol Rep. 2002. PMID: 12379163 Review.

3

Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension.

Segura J, Campo C, Ruilope LM. Segura J, et al. Among authors: campo c. Kidney Int Suppl. 2004 Nov;(92):S45-9. doi: 10.1111/j.1523-1755.2004.09212.x. Kidney Int Suppl. 2004. PMID: 15485417 Free article. Review.

4

Microalbuminuria in essential hypertension.

Rodicio JL, Campo C, Ruilope LM. Rodicio JL, et al. Among authors: campo c. Kidney Int Suppl. 1998 Dec;68:S51-4. doi: 10.1046/j.1523-1755.1998.06813.x. Kidney Int Suppl. 1998. PMID: 9839284 Free article. Review.

5

Correlations of smoothness index and trough-to-peak ratio with left ventricular mass index changes induced by lercanidipine in hypertensive patients. A pilot trial.

Campo C, Saavedra J, Segura J, Roldán C, Ruilope LM, Parati G. Campo C, et al. Minerva Med. 2005 Oct;96(5):365-71. Minerva Med. 2005. PMID: 16227951

6

Hypertensive renal damage in metabolic syndrome is associated with glucose metabolism disturbances.

Segura J, Campo C, Roldán C, Christiansen H, Vigil L, García-Robles R, Rodicio JL, Ruilope LM. Segura J, et al. Among authors: campo c. J Am Soc Nephrol. 2004 Jan;15 Suppl 1:S37-42. doi: 10.1097/01.asn.0000093237.00846.78. J Am Soc Nephrol. 2004. PMID: 14684670

7

Hyperuricemia, low urine urate excretion and target organ damage in arterial hypertension.

Campo C, Ruilope LM, Segura J, Rodicio JL, García-Robles R, Garcia-Puig J. Campo C, et al. Blood Press. 2003;12(5-6):277-83. doi: 10.1080/08037050310019418. Blood Press. 2003. PMID: 14763658

8

Renal participation in cardiovascular risk in essential hypertension.

Ruilope LM, Segura J, Campo C, Rodicio JL. Ruilope LM, et al. Among authors: campo c. Expert Rev Cardiovasc Ther. 2003 Jul;1(2):309-15. doi: 10.1586/14779072.1.2.309. Expert Rev Cardiovasc Ther. 2003. PMID: 15030289 Review.

9

Do we need to target 'prediabetic' hypertensive patients?

Segura J, Campo C, Ruilope LM, Rodicio JL. Segura J, et al. Among authors: campo c. J Hypertens. 2005 Dec;23(12):2119-25. doi: 10.1097/01.hjh.0000191907.11606.cc. J Hypertens. 2005. PMID: 16269951 Review.

10

Chronic kidney disease and global cardiovascular risk in essential hypertension.

Segura J, Campo C, Ruilope LM. Segura J, et al. Among authors: campo c. Minerva Med. 2004 Oct;95(5):375-83. Minerva Med. 2004. PMID: 15467513 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

345 results

Search Page